SOLY News and Press, Soliton Inc. From 05/13/21

Given an Abbvie (ABBV) subsidiary's recent announcement it would acquire Soliton (SOLY) and following the company's solid Q1 results, Cantor Fitzgerald is downgrading the stock to neutral.Analyst Louise Chen is also lowering her price target to $22.60 from $25, implying a ~1% increase. That's...

Soliton Reports First Quarter 2021 Results PR Newswire HOUSTON , May 12, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial resu...

Soliton just announced a definitive agreement to be sold to Allergan Aesthetics, an AbbVie company, for $22.60 a share, valuing the company roughly 100% higher than my initial investment initiation. The acquisition is a smart move for AbbVie, which will get their hands on Soliton's re...

Gainers: Protagenic Therapeutics (PTIX) +67%.Obalon Therapeutics (OBLN) +57%.Precipio (PRPO) +35%.Cue Biopharma (CUE) +31%.SemiLEDs (LEDS) +28%.CKX Lands (CKX) +27%.Tecnoglass (TGLS) +24%.Soliton (SOLY) +24%.Party City Holdco (PRTY) +19%.uCloudlink (UCL) +16%.Losers: Rekor...

Allergan Aesthetics, an AbbVie (ABBV) company, and Soliton (SOLY) announced a definitive agreement under which the former will acquire the latter and RESONIC, its Rapid Acoustic Pulse device which recently received U.S. FDA; it is a non-invasive treatment for the short-term improvem...

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio -- Acquisition adds Rapid Acoustic Pulse technology platform for improvement in appearance of cellulite in the buttocks and thighs -- PR Newswire IRVINE, Calif. and HOUSTON , May 10...

Introducing RESONIC™ Soliton, Inc. Rolls Out Its Rapid Acoustic Pulse™ Technology with a Multi-Platform Device Indicated for Tattoo Removal and Cellulite Treatment with First Shipments in June PR Newswire HOUSTON , May 5, 2021 /PRNewswire/ --&#x...

Soliton to Report First Quarter 2021 Financial Results on May 13, 2021 Conference Call to Discuss Results on May 13, 2021 at 4:30 p.m. ET PR Newswire HOUSTON , May 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company")...

Soliton (SOLY) announces that the U.S. FDA has given clearance for the company's special 510k for modifications to its RESONIC device, used in tattoo removal and cellulite treatment.The RESONIC device utilizes the RAP technology to deliver safe and effective tattoo removal and cellulite ...

Soliton Announces Oral Presentation at American Society for Laser Medicine and Surgery Virtual Annual Conference PR Newswire HOUSTON , April 27, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company wit...